Adagene share price logo

Adagene

NASDAQ: ADAG

$3.51

-0.17

(-4.62%)

as on

Adagene Stock Performance

as on September 1, 2026 at 2:15 pm IST

  • Day's Low

    Day's High

    $3.45
    $3.62
    downward going graph

    1.71%

    Downside

    3.13%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $1.30
    $4.85
    downward going graph

    62.96%

    Downside

    38.18%

    Upside

    downward going graph

Adagene share price movements today

Previous Close
$3.68
Open
$3.62
Volume
284.6K
Market Cap
$247.1M
Day's Low - High
$3.45 - $3.62
52 Week Low - High
$1.30 - $4.85

Adagene Historical Returns

1 Month Return
-1.87 %
3 Month Return
-7.3 %
1 Year Return
+ 72.77 %
3 Year Return
+ 170.59 %
5 Year Return
-77.23 %

Adagene Stock Fundamentals & Key Indicators

Check Adagene market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$247.1M

EPS (TTM)

-0.47

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-7.88

Industry PE ratio

-1.6496124031007753

PEG Ratio

-0.07883443708609272

EBITDA

-20.9M

Revenue (TTM)

7.7M

Profit Margin

92.43%

Return On Equity TTM

-48.20%

Adagene Stock Valuation

Track how Adagene P/E has moved over time to understand its valuation trends.

Adagene in the last 5 years

  • Overview

  • Trends

Lowest (-4.09x)

March 31, 2026

Today (-4.09x)

March 31, 2026

Industry (-1.65x)

March 31, 2026

Highest (-0.57x)

December 31, 2022

LowHigh

Today’s Price to Earnings Ratio: -4.09x

Adagene vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Adagene with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
BUY$247.1M-77.23%-7.8892.43%NA
BUY$44.6B614.61%NA0.00%NA
BUY$137.2B170.45%31.9286.04%NA
BUY$55.1B-63.37%-7.98-12.57%NA
BUY$85.8B17.94%19.984.86%0.44%

Stock Returns calculator for Adagene Stock including INR - Dollar returns

The Adagene stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

Adagene investment value today

Current value as on today

₹1,77,783

Returns

₹77,783

(+77.78%)

Returns from Adagene Stock

₹64,789 (+64.79%)

Dollar Impact

₹12,994 (+12.99%)

Analyst Recommendation on Adagene Stock

Based on 3 analysts

BUY

66.67%

Buy

33.33%

Hold

0.00%

Sell

Based on 3 analysts, 66.66666666666666% of analysts recommend a 'BUY' rating for Adagene. Average target price of $10.74

Adagene Share Price Target

Get share price movements and forecasts by analysts on Adagene.

What analysts predicted

67.32%UPSIDE

Target Price

$10.74

Current Price

$3.51

Analyzed by

3 Analysts

Target

$10.74

Adagene target price $10.74, a slight upside of 67.32% compared to current price of $3.51. According to 3 analysts rating.

Indian Investors' Interest in Adagene Stock

Search interest for Adagene Stock has decreased by -37% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-37% versus previous 30 day period

Adagene Quarterly Profit & Loss

All numbers in Millions USD

Dec 2022
Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Dec 2024
Jun 2025
Mar 2026
Total Revenue
2
8
8
0
0
-
-
0
-
7
Gross Profit
0
8
17
0
0
-
0
0
0
7
Operating Income
-17
-2
-2
-9
-9
-9
-9
-26
-15
-5
EBITDA
-17
-2
-2
-9
-9
-8
-8
-22
-15
-5
Interest Expense
0
-
0
-
0
-
0
0
0
0
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-16
0
0
-7
-7
-8
-8
-24
-13
-4
Income Tax Expense
0
1
1
0
0
0
0
0
-
0
Net Income
-16
-2
-2
-7
-7
-8
-8
-24
-13
-4
Net Profit Margin
0.91%
100.00%
0.00%
100.00%
-4.31%
0.00%
0.00%
-797.49%
0.00%
96.33%

Adagene Annual Profit & Loss

All numbers in Millions USD

Dec 2018
Dec 2019
Mar 2021
Mar 2022
Dec 2022
Dec 2023
Dec 2024
Mar 2026
Total Revenue
1
0
0
10
9
18
0
7
Gross Profit
1
0
0
10
9
18
0
7
Operating Income
-17
-19
-19
-72
-83
-23
-35
-21
EBITDA
-14
-15
-41
-69
-77
-14
-31
-16
Interest Expense
0
0
0
0
0
1
0
0
Depreciation
0
0
0
1
1
1
0
0
Income Before Tax
-15
-16
-16
-71
-79
-17
-33
-17
Income Tax Expense
0
-
0
1
0
1
0
0
Net Income
-14
-17
-16
-73
-79
-18
-33
-17
Net Profit Margin
100.00%
100.00%
100.00%
100.00%
100.00%
100.00%
-797.49%
100.00%

Adagene Quarterly Cash Flow

All numbers in Millions USD

Dec 2022
Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Dec 2024
Jun 2025
Mar 2026
Net Income
-16
-2
-2
-7
-7
-8
-8
-24
-13
-4
Operating Cash Flow
14
-6
-6
-
-15
-6
-6
-23
-11
-4
Investing Cash Flow
-5
0
0
-
-
0
0
0
0
0
Financing Cash Flow
-56
0
0
-
-
0
-1
5
-11
16
Change in Cash
-24
-7
-14
-128
-18
-7
-7
-10
-22
11

Adagene Annual Cash Flow

All numbers in Millions USD

Dec 2018
Dec 2019
Mar 2021
Mar 2022
Dec 2022
Dec 2023
Dec 2024
Mar 2026
Net Income
-15
-16
-42
-73
-79
-18
-33
-17
Operating Cash Flow
-14
-18
-28
-43
-48
-28
-29
-15
Investing Cash Flow
-29
24
7
-2
0
0
1
0
Financing Cash Flow
51
69
4
145
17
-5
3
4
Change in Cash
7
76
-17
99
-30
-33
-24
-10

Mutual Funds that own Adagene Stock

Check out the Mutual Funds with significant holdings in Adagene.

Funds
Holdings
Shares Held
Fidelity Concord Street Trust
0.015353%
10309

Global Institutional Holdings in Adagene

Funds
Holdings
James E. Flynn
3.97%
Invesco
0.06%

Adagene News & Key Events

    Insights on Adagene

    Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

    • imgPOSITIVE IMPACT

      Best in 3 Years

      img

      In the last 3 years, ADAG has outperformed top 5 stocks with highest market-cap in its industry

    • imgNO EFFECT

      Against Peers

      img

      In the last 1 year, Moderna, Inc. Common Stock has given 482.6% return, outperforming this stock by 417.8%

    • imgNEGATIVE IMPACT

      Profit Down

      img

      Netprofit is down for the last 2 quarters, -4.14M → -16.41M (in $), with an average decrease of 296.1% per quarter

    • imgNEGATIVE IMPACT

      Revenue Fall

      img

      Revenue is down for the last 2 quarters, 7.69M → 1.62M (in $), with an average decrease of 78.9% per quarter

    • imgNEGATIVE IMPACT

      Price Dip

      img

      In the last 7 days, ADAG stock has moved down by -8.1%

    About Adagene

    Adagene Inc., a clinical stage biotechnology company, engages in the research, development, and production of monoclonal antibody drugs for cancers in the People's Republic of China. Its lead product candidate is the ADG126, a masked fully-human anti-CTLA-4 mAb which is in phase 1b/2 clinical development for the treatment of cancer. The company also develops ADG116, a fully human anti-CTLA-4 antibody generated using NEObody technology, which is in phase 1b/2 clinical trials to treat advanced/metastatic solid tumors; ADG206, which is in phase 1 clinical development to treat advanced metastatic solid tumors; ADG104, anti-PD-L1 monoclonal antibody which is in phase 2 clinical development; and ADG125, a novel anti-CSF-1R mAb which is in Phase 2 clinical development. In addition, it is developing ADG138, a HER2xCD3 POWERbody which is in pre clinical trial to treat low expressing tumors, as well as resistant/refractory tumors; ADG152, a CD20xCD3 POWERbody which is in preclincal trial to treat off-tumor toxicities; ADG153, a masked anti-CD47 IgG1 SAFEbody, wihx is in preclinical trial for the treatment of hematologic and solid tumor; and CD28 T-cell engagers, an anti-CD28 bispecific POWERbody TCEs to treat solid tumors. Adagene Inc. was incorporated in 2011 and is headquartered in Suzhou, China.
    OrganisationAdagene
    HeadquartersBuilding C14, Suzhou, China, 215123
    IndustryBiotechnology
    CEODr. Peter P. Luo Ph.D.
    E-voting on sharesClick here to vote

    Key Management of Adagene

    Name

    Title

    Ms. Ling Zhou

    Executive Director & Head of Human Resources

    Dr. Qinghai Zhao Ph.D.

    Chief Manufacturing Officer

    Ms. Chunfang Gu

    Executive Director of Finance

    Ms. Xiaohong She

    Senior VP & Head of Clinical Operations

    Dr. Guizhong Liu Ph.D.

    Senior Vice President of Early Drug Discovery

    Mr. Alexander Goergen

    VP & Head of Business Development

    Mr. Man Kin Tam M.B.A.

    CFO & Director

    Mr. Mickael Chane-Du

    Chief Strategy Officer

    Ms. Yan Li M.B.A.

    Senior Vice President of Bioinformatics & Information Technology

    Dr. Peter P. Luo Ph.D.

    Co- Founder, Chairman, CEO and President of R&D

    FAQs

    What is Adagene share price today?

    Adagene share price today is $3.51 as on at the close of the market. Adagene share today touched a day high of $3.62 and a low of $3.45.

    What is the 52 week high and 52 week low for Adagene share?

    Adagene share touched a 52 week high of $4.85 on and a 52 week low of $1.30 on . Adagene stock price today i.e. is closed at $3.51,which is 27.63% down from its 52 week high and 170.00% up from its 52 week low.

    What is Adagene's market capitalisation today?

    Adagene market capitalisation is $0.00T as on .

    How to invest in Adagene Stock (ADAG) from India?

    1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
    2. Step 2: Search for Adagene on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Adagene Shares that will get you 0.4274 shares as per Adagene share price of $3.51 per share as on September 1, 2026 at 8:45 am IST.

    What is the minimum amount required to buy Adagene Stock (ADAG) from India?

    Indian investors can start investing in Adagene (ADAG) shares with as little as ₹94.94 or $1 (as of ) using the INDmoney app.
    For example: If you want to invest $10 or ₹949.40 in Adagene stock (as per the Rupee-Dollar exchange rate as on ). Based on Adagene share’s latest price of $3.51 as on September 1, 2026 at 8:45 am IST, you will get 2.8490 shares of Adagene. Learn more about fractional shares .

    What are the returns that Adagene has given to Indian investors in the last 5 years?

    Adagene stock has given -77.23% share price returns and 30.37% dollar appreciation to an Indian investor in the last 5 years.
    Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?